CUMBERLAND PHARMACEUTICALS INC (CPIX) › Operating IncomeCUMBERLAND PHARMACEUTICALS INC (CPIX) — Operating IncomeAnnual figures by fiscal year, from SEC filings.2009: $5.78M2010: $6.50M2011: $9.85M2012: $8.82M2013: -$3.80M2014: $3.56M2015: $1.11M2016: -$1.43M2017: -$4.08M2018: -$11.17M2019: -$9.29M2020: -$6.38M2021: -$7.68M2022: -$5.70M2023: -$9.55M2024: -$6.43M2025: -$2.79M-$2.79M2009Operating Income (USD)2025Fiscal YearOperating IncomeChange YoY2025-$2.79M+56.6%2024-$6.43M+32.7%2023-$9.55M-67.5%2022-$5.70M+25.7%2021-$7.68M-20.3%2020-$6.38M+31.3%2019-$9.29M+16.9%2018-$11.17M-173.8%2017-$4.08M-184.8%2016-$1.43M-228.9%2015$1.11M-68.8%2014$3.56M+193.6%2013-$3.80M-143.1%2012$8.82M-10.5%2011$9.85M+51.5%2010$6.50M+12.6%2009$5.78M—Other metrics: RevenueCost of RevenueGross ProfitNet IncomeEPS (Diluted)Total AssetsTotal LiabilitiesShareholders' EquityCash & EquivalentsOperating Cash FlowCapital ExpendituresShares OutstandingDividends Per Share